Biotech

All Articles

FDA areas Kezar lupus trial in grip adhering to 4 client fatalities

.The FDA has actually put Kezar Life Sciences' lupus trial on grip after the biotech flagged 4 fatal...

Phase 3 Intellectual Rock test hits SMA objective, delivering stock up 200%

.A stage 3 test of Historian Rock's vertebral muscle degeneration (SMA) candidate has actually struc...

CAMP 4 is newest to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapeutics has defined plans for a $67 million IPO, with inflammation-focused U...

Galecto gets leukemia medicine, falls bone cancer cells possession in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis applicant sent Galecto on a seek sal...

Judo throws down $100M to knock out renal ailment

.Taking the floor covering is Judo Bio, a promising biotech armed with $100 thousand to establish ol...

AstraZeneca spends CSPC $100M for preclinical heart problem medicine

.AstraZeneca has actually paid off CSPC Drug Team $one hundred million for a preclinical cardiovascu...

Zephyrm finds Hong Kong IPO to finance period 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, declaring (PDF) for an IPO to b...

Frazier Life Sciences gathers $630M for tiny, mid-cap biotechs

.Frazier Daily life Sciences has sourced a further $630 million for its fund focused on small and mi...

GigaGen gets up to $135M BARDA dollars to hammer botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technicia...

GPCR agency Septerna files for IPO on strength of preclinical records

.Septerna is about to discover just how a biotech without "any sort of purposeful scientific data" f...